What is Semaglutide?
Semaglutide is a GLP-1 receptor agonist. The medicine acts on GLP-1 receptors; qualified clinicians evaluate its potential benefits, contraindications, adverse effects and approved uses for a particular patient.
Semaglutide is prescribed for specific indications including type 2 diabetes or weight management under relevant labels; the exact authorised uses depend on the product and jurisdiction. Read the MedlinePlus medicine monograph for medicine-specific safety information and the WHO obesity treatment guideline overview for broader context.
How is it different from other GLP-1 treatments?
Products containing semaglutide are not identical merely because the active ingredient name matches. Formulation, strength, indication, labelling and registration must be checked separately. The side-by-side treatment comparison can help organise questions for a doctor; it does not determine suitability.
Check registration country by country
Thailand update: For registered Wegovy products and the prescription rules introduced in September 2026, see our Wegovy in Thailand guide, based on official Thai FDA records.
Approval status is product-specific and country-specific. Follow the national official source for the medicine name or registration number, verify the label and ask a qualified local prescriber about the current position. The six country guides are below.
- Thailand · THB — official regulator
- Malaysia · MYR — official regulator
- Vietnam · VND — official regulator
- Singapore · SGD — official regulator
- Indonesia · IDR — official regulator
- The philippines · PHP — official regulator
Questions to bring to a consultation
- Which exact semaglutide brand, presentation and indication is registered locally?
- What does follow-up include if the medicine is appropriate for me?
- How will the clinician review side effects and other medicines?
Ask what monitoring and ongoing visits are expected. Where a provider quotes a monthly amount, compare it with initial visits, diagnostic testing, follow-up and dispensing costs to understand the total.
Frequently asked questions
Is semaglutide registered in every country in Asia?
Do not assume so. Check each national regulator’s current register for the exact brand, formulation and permitted indication.
How does semaglutide work?
It is a GLP-1 receptor agonist and acts via GLP-1 receptors. Individual treatment decisions depend on the licensed label and clinical assessment.
What should an advertised treatment price include?
Request separate consultation, tests, prescription, dispensing and follow-up charges in local currency.
Is the GLP1Asia clinic directory a recommendation?
No. The directory links to service websites; current prescribing services and registration require confirmation.